Before the Door Closes
Treatment Guides
Close readings of regenerative and aesthetic protocols in the Gangnam clinic quarter — what a procedure is, what it is not, and the questions worth having ready while the consultation room is still open to you.
The Close Reading
Umbilical Cord-Derived Stem Cells: An Overview
A measured reading of UC-MSC therapy — what the cells actually are, where the indications stand, and how the Korean clinics organise the protocol.
Read article →The Close Reading
An Introduction to Stem Cell Therapy: A Reader's First Pass
A measured primer for the non-specialist — what the cells are, how the protocols read, and where the science remains genuinely undramatic.
Read article →The Close Reading
Rotator Cuff Injuries and Stem Cell Therapy: A Gangnam Reading
An editorial reading of stem cell options for rotator cuff tears — measured, hedged, and grounded in what the protocols actually do.
Read article →The Close Reading
Stem Cell Therapy for Knee Osteoarthritis: A Patient's Reading
An editorial reading of mesenchymal stem cell protocols for knee osteoarthritis — the indication gating, the recovery arc, and the months-not-weeks tempo that the Gangnam clinics build into…
Read article →The Close Reading
Stem Cell-Based Hair Restoration: A Reader's Map
Cell-based hair restoration read carefully — the indication, the comparison with finasteride and FUE, and the long window before legibility.
Read article →The Close Reading
Stem Cells in 'General Wellness' Programs: What to Read Critically
An editorial — not a recommendation — on how to read immune, anti-ageing, and longevity claims attached to regenerative therapies in Asia.
Read article →The Close Reading
Disc Degeneration and Stem Cell Approaches: A Gangnam Reading
Where cellular therapy fits in the conversation about degenerative disc disease — and where, in honest practice, it does not.
Read article →The Close Reading
Cellular Approaches to Skin Rejuvenation: A Reader's Guide
Cell-based and exosome-derived rejuvenation read the way Mid-Levels reads — quietly, vertically, with codes that reward slow attention.
Read article →The Close Reading
Safety Profile and Side Effects: A Long-Read
An editorial reading of what the data — and the consultation room — currently say about autologous stem cell tolerability, the rare events, and the longer-tail unknowns.
Read article →The Close Reading
Stem Cell Research Frontier in 2026: An Editor's Reading
A measured, non-expert summary of where regenerative medicine sits this year — written for the curious, not the credulous.
Read article →The Close Reading
Week One: What Recovery Looks Like After Regenerative Care
A day-by-day editorial — cadence, vitals, sleep, hydration, and the small editorial discipline that earns the second week.
Read article →The Close Reading
Six Months and Beyond: Long Arc of Cellular Therapy
Six-month, twelve-month, eighteen-month — how the curve reads at distance, and when retreatment is the considered answer.
Read article →The Close Reading
Recovery Protocol Updates: An International Consensus Read
What the 2026 consensus drafts on cellular therapy aftercare quietly recommend — and what they leave open.
Read article →The Close Reading
Month One to Three: The Slow Curve of Recovery
An editorial reading of the second-month plateau — what the literature suggests, what patients report, and how to read the slow curve.
Read article →The Close Reading
PRP and Stem Cell Therapy: Where the Two Diverge — A Reading
An editorial reading of the mechanism gap between platelet-rich plasma and stem cell protocols — and why Gangnam's clinicians no longer treat the two as interchangeable.
Read article →The Close Reading
The Pre-Treatment Workup: A Checklist Reader Can Bring
Imaging, bloodwork, medication review, and the unhurried questions one should walk into a Gangnam consultation already holding.
Read article →The Close Reading
Multi-Day Treatment Coordination: A Logistics Read
A measured guide to scheduling a three-to-seven-day treatment window in Gangnam — for the cosmopolitan traveller who would rather plan once, carefully, than improvise twice.
Read article →The Close Reading
MFDS Classification of Stem Cell Therapies, Explained
How Korea's Ministry of Food and Drug Safety draws the line between drug and procedure — and why the distinction reads, on close inspection, rather more carefully than…
Read article →The Close Reading
Medications and Supplements to Pause Before Treatment
An unhurried reading of the pre-procedure pause list — anticoagulants, herbal preparations, and the supplements one rarely thinks to mention.
Read article →The Close Reading
Labs and Imaging Before Stem Cell Therapy: A Reader's Frame
The panels, the modalities, the timing windows, and the unhurried rationale a responsible Gangnam clinic should set out before the protocol begins.
Read article →The Close Reading
Korean Medical Tourism Statistics 2026: An Editor's Read
The KHIDI and KTA figures, read carefully — patient counts, country mix, treatment shares, and the quiet caveats the headline numbers tend to leave out.
Read article →The Close Reading
Reading the Global Stem Cell Map: Korea Among Peers
A measured comparison of Korea, Thailand, and Mexico as stem cell destinations — regulation, protocol culture, and the reading that survives a closer look.
Read article →The Close Reading
Korea and Japan: Two Regulatory Approaches to Cellular Therapy
Two East Asian frameworks, two answers to the same question — read carefully from the patient's seat rather than the regulator's.
Read article →The Close Reading
KHIDI and the Foreign Patient: Why This Agency Matters
A registry, a regulator, and a quiet logistical infrastructure — the KHIDI ecosystem, read carefully.
Read article →The Close Reading
Insurance and Cellular Therapy: A Realistic Reading
What the policies cover, what they decline, and what the careful patient learns to budget for in advance.
Read article →The Close Reading
Reading the Informed Consent: A Line-by-Line Guide
What each clause of the consent document is doing, in plain language — for the cosmopolitan reader who would rather sign carefully than quickly.
Read article →The Close Reading
Follow-Up From Overseas: A Continuity-of-Care Guide
An editorial reading of how the careful Seoul room — and the careful guest — sustain a regenerative-medicine course across the seas, the time zones, and the months…
Read article →The Close Reading
Exosomes as an Adjunct: Reading the Evidence
A measured editorial reading of exosomes — what the vesicles actually carry, how Gangnam programmes pair them with stem cells, and where the evidence is honest about itself.
Read article →The Close Reading
Cost Transparency: Reading a Korean Stem Cell Quote
An unhurried reading of the line items — exam, harvest, procedure, aftercare — and the questions one asks before signing.
Read article →The Close Reading
Contraindications: When Stem Cell Therapy Is Not Indicated
An editorial reading of the absolute exclusions, the relative deferrals, and the indications for which an adjacent pathway is the more honest answer.
Read article →The Close Reading
Stem Cell Therapy vs. Surgery: A Decision Framework Approach
An editorial reading of the decision arc between cellular therapy and surgical intervention — and how Gangnam's better consults sequence the two rather than oppose them.
Read article →The Close Reading
Stem Cell vs. Prolotherapy: A Patient's Comparative Reading
A measured editorial reading of stem cell therapy alongside prolotherapy — what diverges in mechanism, what overlaps in indication, and what Gangnam clinicians weigh at the consult.
Read article →The Close Reading
Stem Cell vs. Hyaluronic Acid Injection: When Each Makes Sense
A measured reading of the indication gap between cellular therapy and hyaluronic acid — and why Gangnam's better consults treat the two as different conversations.
Read article →The Close Reading
Cell Counts and Quality Metrics: A Reader's Glossary
An editorial reading of total nucleated cell counts, viability percentages, surface-marker phenotyping, and the other numbers a Seoul lab printout offers — and the careful boundaries of what…
Read article →The Close Reading
Bone Marrow MSCs: A Long-Read Primer
A reading of bone marrow mesenchymal stromal cells — the iliac aspirate, the heterogeneity, and the hedged claims the field currently supports.
Read article →The Close Reading
Autologous vs. Allogeneic Stem Cells, Explained
Self-derived versus donor-derived — a careful reading of the distinction the consumer press tends to flatten.
Read article →The Close Reading
Adipose-Derived SVF: What the Cells Actually Do
An unhurried reading of stromal vascular fraction — the populations within, the extraction logic, and the hedged claims the science currently supports.
Read article →